Renee is an associate patent attorney with experience in Australian and New Zealand patent drafting, prosecution, opposition and freedom to operate advisory services.
Renee works across a spectrum of life sciences fields including biochemistry, molecular and cellular biology, stem cells, agritechnology, pharmaceuticals, methods of medical treatment and prevention, biomarkers and immunology, including antibody technologies, diagnostics, food technology, and veterinary sciences.
Renee graduated from Monash University with a PhD in Biochemistry and was a postdoctoral researcher at the Burnet Institute, with experience in HIV and complement proteases. She was awarded a prestigious Peter Doherty Biomedical Research Fellowship.
After completing commercialisation training in the Molecules to Medicine programme, Renee developed a passion for bridging the gap between researchers and industry with an aim to drive global translational research outcomes. This continues to be one of her drivers as a patent attorney, to assist a wide range of clients, from large corporations to universities and small spinout companies, to capitalise on their cutting-edge technology.
Prior to joining Pearce IP, Renee was an Associate at Watermark and then Griffith Hack.
Australian Law Awards (Lawyers Weekly)
IAM Patent 1000
Managing IP Stars
Firm: Pearce IP ranked – Tier 3 prosecution (2022)
Recognised as a Rising Star (2021, 2022)
Women in Business Law Awards – APAC
Shortlisted: Australian Firm of the Year (2022)
Australasian Lawyer 5-Star Awards
5-Star Intellectual Property Law Firm: Pearce IP (2021)
Lexology Legal Influencer
Healthcare and Life Sciences (Australasia): Pearce IP (Q2 2022, Q1 2021, Q4 2020)
Healthcare and Life Sciences (Cross-border): Pearce IP (2021)
Ranked as a market leading Intellectual Property firm (2023)
By 2027, be the premier life sciences IP practice in
Australia and New Zealand.